1. Raess, Matthieu A, Cowling, Belinda S, Bertazzi, Dimitri L, Friant, Sylvie, Laporte, Jocelyn. . Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy. In Human molecular genetics, 26, 3736-3748. doi:10.1093/hmg/ddx258. https://pubmed.ncbi.nlm.nih.gov/28934386/
2. Wang, J, He, A-L, Zhang, W-G, Liu, H-L, Ma, X-R. . MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1. In European review for medical and pharmacological sciences, 24, 8057-8066. doi:10.26355/eurrev_202008_22489. https://pubmed.ncbi.nlm.nih.gov/32767332/
3. Jiang, Lei, Liu, Jun-Yan, Shi, Yan, Cui, You-Hong, Yu, Pei-Wu. 2019. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling. In Journal of experimental & clinical cancer research : CR, 38, 206. doi:10.1186/s13046-019-1186-z. https://pubmed.ncbi.nlm.nih.gov/31113461/
4. Yao, Yuanqian, Lai, Jiawen, Yang, Yuwen, Wang, Guangyao, Lv, Jianlin. 2023. An integrative analysis reveals the prognostic value and potential functions of MTMR2 in hepatocellular carcinoma. In Scientific reports, 13, 18701. doi:10.1038/s41598-023-46089-w. https://pubmed.ncbi.nlm.nih.gov/37907649/
5. Chojnowski, Alexandre, Ravisé, Nicole, Bachelin, Corinne, Baron-Van Evercooren, Anne, LeGuern, Eric. 2007. Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells. In Neurobiology of disease, 26, 323-31. doi:. https://pubmed.ncbi.nlm.nih.gov/17336078/
智鼠故事 
